Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 8;10(2):300-309.
doi: 10.1039/c8md00540k. eCollection 2019 Feb 1.

Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions

Affiliations

Methoxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A AR antagonists for the potential treatment of neurological conditions

Helena D Janse van Rensburg et al. Medchemcomm. .

Abstract

A prior study reported on hydroxy substituted 2-benzylidene-1-indanone derivatives as A1 and/or A2A antagonists for the potential treatment of neurological conditions. A lead compound (1a) was identified with both A1 and A2A affinity in the micromolar range. The current study explored the structurally related methoxy substituted 2-benzylidene-1-indanone derivatives with various substitutions on ring A and B of the benzylidene indanone scaffold in order to enhance A1 and A2A affinity. This led to compounds with both A1 and A2A affinity in the nanomolar range, namely 2c (A1 K i (rat) = 41 nM; A2A K i (rat) = 97 nM) with C4-OCH3 substitution on ring A together with meta (3') hydroxy substitution on ring B and 2e (A1 K i (rat) = 42 nM; A2A K i (rat) = 78 nM) with C4-OCH3 substitution on ring A together with meta (3') and para (4') dihydroxy substitution on ring B. Additionally, 2c is an A1 antagonist. Consequently, the methoxy substituted 2-benzylidene-1-indanone scaffold is highly promising for the design of novel A1 and A2A antagonists.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. The structures of ASP-5854 and JNJ-40255293.
Fig. 2
Fig. 2. The structures and Ki values of compounds structurally related to benzylidene indanones and the structural modifications to lead compound 1a to determine features essential for dual A1/A2A AR affinity.
Scheme 1
Scheme 1. Synthesis of 2a–g, 2i, 2k & 2m. Reagents and conditions: a) acetone, K2CO3, MeI, 50 °C (18 h); b) MeOH, HCl (32%), 120 °C (24 h).
Fig. 3
Fig. 3. Structural requirements of the 2-benzylidene-1-indanone scaffold for dual A1/A2A affinity.
Fig. 4
Fig. 4. The binding curves of compounds 2c and CPA (reference compound) are examples of A1 AR antagonistic action (A) and A1 AR agonistic action (B), respectively, determined via a GTP shift assays (with and without 100 μM GTP) in rat whole brain membranes expressing A1 ARs with [3H]DPCPX as radioligand. (A) GTP shift of 1.46 calculated for compound 2c, (B) GTP shift of 15 calculated for compound CPA.

Similar articles

Cited by

References

    1. Soliman A. M., Fathalla A. M., Moustafa A. A. Pharmacol. Rep. 2018;70(4):661–667. - PubMed
    1. Palmer T. M., Stiles G. L. Neuropharmacology. 1995;34(7):683–694. - PubMed
    1. Ross G. W., Abbot R. D., Petrovitch H., Morens D. M., Grandinetti A., Tung K. H., Tanner C. M., Masaki K. H., Blanchette P. L., Curb J. D., Popper J. S. JAMA, J. Am. Med. Assoc. 2000;283(20):2674–2679. - PubMed
    1. Prediger R. D. S., Ribeiro J. A., Sebastião A. M. J. Alzheimers Dis. J. Alzheimer's Dis. 2010;2010;2020(S1)(S1):S205–S2205. S3–S15. - PubMed
    1. Ribeiro J. A., Sebastião A. M. J. Alzheimer's Dis. 2010;20(S1):S3–S15. - PubMed